Background: Vascular complications (VCs) still represent one of the principal concerns of trans-femoral trans-catheter aortic valve replacement (TF-TAVR). New-generation devices can minimize such complications but the arterial access management is left to the operator's choice. This study aims to describe the rate of VCs in a contemporary cohort of patients undergoing TAVR with new-generation devices and to determine whether an ultrasound-guided (USG) vs. a fluoroscopy-guided (FG) femoral access management has an impact on their prevention. Methods: This is a prospective, observational, multicenter study. Consecutive patients undergoing TAVR with new-generation devices were analyzed from January 2022 to October 2022 in five tertiary care centers. Femoral accesses were managed according to the operator's preferences. All the patients underwent a pre-discharge peripheral ultrasound control. VCs and bleedings were the main endpoints of interest. Results: A total of 458 consecutive patients were enrolled (274 in the USG group and 184 in the FG group). VCs occurred in 6.5 % of the patients (5.2 % minor and 1.3 % major). There was no difference between the USG and the FG groups in terms of any VCs (7.3 % vs. 5.4 %; p = 0.4), or any VARC-3 bleedings (6.9 % vs 6 %, p = 0.9). At logistic regression analysis, the two guidance strategies did not result as predictors of VCs (odds Ratio 0.8, 95 % Confidence Interval 0.46-1.4; P = 0.4). Conclusions: In a contemporary cohort of patients undergoing TAVR with new-generation devices, the occurrence of VCs is low and mostly represented by minor VCs. USG and FG modalities did not affect the rate of VCs.

Bianchini, E., Morello, A., Bellamoli, M., Romagnoli, E., Aurigemma, C., Tagliaferri, M., Montonati, C., Dumonteil, N., Cimmino, M., Villa, E., Corcione, N., Bettari, L., Messina, A., Stanzione, A., Troise, G., Mor, D. A., Maggi, A., Bellosta, R., Pegorer, M. A., Zoccai, G. B., Ielasi, A., Burzotta, F., Trani, C., Maffeo, D., Tchétché, D., Buono, A., Giordano, A., Comparison of ultrasound- versus fluoroscopy-guidEd femorAl access In tranS-catheter aortic valve replacement In the Era of contempoRary devices: The EASIER registry, <<CARDIOVASCULAR REVASCULARIZATION MEDICINE>>, 2023; (23 dec): N/A-N/A. [doi:10.1016/j.carrev.2023.12.007] [https://hdl.handle.net/10807/260618]

Comparison of ultrasound- versus fluoroscopy-guidEd femorAl access In tranS-catheter aortic valve replacement In the Era of contempoRary devices: The EASIER registry

Bianchini, Emiliano;Romagnoli, Enrico;Aurigemma, Cristina;Troise, Giovanni;Mor, Donata Angela;Pegorer, Matteo Alberto;Burzotta, Francesco;Trani, Carlo;
2023

Abstract

Background: Vascular complications (VCs) still represent one of the principal concerns of trans-femoral trans-catheter aortic valve replacement (TF-TAVR). New-generation devices can minimize such complications but the arterial access management is left to the operator's choice. This study aims to describe the rate of VCs in a contemporary cohort of patients undergoing TAVR with new-generation devices and to determine whether an ultrasound-guided (USG) vs. a fluoroscopy-guided (FG) femoral access management has an impact on their prevention. Methods: This is a prospective, observational, multicenter study. Consecutive patients undergoing TAVR with new-generation devices were analyzed from January 2022 to October 2022 in five tertiary care centers. Femoral accesses were managed according to the operator's preferences. All the patients underwent a pre-discharge peripheral ultrasound control. VCs and bleedings were the main endpoints of interest. Results: A total of 458 consecutive patients were enrolled (274 in the USG group and 184 in the FG group). VCs occurred in 6.5 % of the patients (5.2 % minor and 1.3 % major). There was no difference between the USG and the FG groups in terms of any VCs (7.3 % vs. 5.4 %; p = 0.4), or any VARC-3 bleedings (6.9 % vs 6 %, p = 0.9). At logistic regression analysis, the two guidance strategies did not result as predictors of VCs (odds Ratio 0.8, 95 % Confidence Interval 0.46-1.4; P = 0.4). Conclusions: In a contemporary cohort of patients undergoing TAVR with new-generation devices, the occurrence of VCs is low and mostly represented by minor VCs. USG and FG modalities did not affect the rate of VCs.
2023
Inglese
Bianchini, E., Morello, A., Bellamoli, M., Romagnoli, E., Aurigemma, C., Tagliaferri, M., Montonati, C., Dumonteil, N., Cimmino, M., Villa, E., Corcione, N., Bettari, L., Messina, A., Stanzione, A., Troise, G., Mor, D. A., Maggi, A., Bellosta, R., Pegorer, M. A., Zoccai, G. B., Ielasi, A., Burzotta, F., Trani, C., Maffeo, D., Tchétché, D., Buono, A., Giordano, A., Comparison of ultrasound- versus fluoroscopy-guidEd femorAl access In tranS-catheter aortic valve replacement In the Era of contempoRary devices: The EASIER registry, <<CARDIOVASCULAR REVASCULARIZATION MEDICINE>>, 2023; (23 dec): N/A-N/A. [doi:10.1016/j.carrev.2023.12.007] [https://hdl.handle.net/10807/260618]
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10807/260618
Citazioni
  • ???jsp.display-item.citation.pmc??? 0
  • Scopus 0
  • ???jsp.display-item.citation.isi??? ND
social impact